Mandate

VINGE ADVISES SHANGHAI XINGXUEKANG IVESTMENT PARTNERSHIP IN CONNECTION WITH THE ACQUISITION OF OPCON ENERGY SYSTEMS SVENSAK ROTORMASKINER

July 02, 2015

XingXueKang Investment Partnership has entered into a share purchase agreement with Opcon, the energy and environmental technology group a share purchase agreement concerning the sale of Opcon’s main part of the group’s operations within compressor technology and waste heat recovery. The transaction also includes the newly-formed company, Opcon Compressor Technology AB as well as the subsidiaries Svenska Rotor Maskiner AB, Opcon Energy System AB and 48.9796% of the shares in the jointly owned Chinese company Fuijan Opcon Energy Technology Co. Ltd. The transaction also includes all intellectual property rights related to compressor technology and Opcon Powerbox. The Opcon trademark will also be assigned although it will continue to be used by the Opcon group during a transitional period.

Following completion of the due diligence phase based on the accounts as per 31 March 2015, the purchase price amounts to SEK 400 million. Fifteen per cent of the purchase price will be paid in cash not later than 20 business days after the agreement enters into force following approval by the members at Opcon’s general meeting and approval by the investment committee which controls the purchaser. The remaining 85% of the purchase price shall be paid at closing of the transaction, which is anticipated to occur on 30 September 2015 when title to the shares passes to the purchaser.

Vinge’s team consisted of responsible counsel Qun Gu and Ulrich Ziche (project manager), and Andrea Jägerstedt (M&A), Johan Cederblad, Niclas Winnberg and Julia Nääs (real estate and environmental), Karin Grauers (commercial agreements, IP and IT), Maria Schultzberg (tax), Johan Wahlbom (competition) and project assistants Annika Johnson and Carline Skymberg.

For further information, please see Opcon’s press release: www.opcon.se

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024